Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pemphigus

• Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
• Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid
• A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
• A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
• Dexamethasone Solution and Dexamethasone in Mucolox™
• IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
• Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
• Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial
• A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris
• A Study of PRN1008 in Patients With Pemphigus
• A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
• A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
• Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
• Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
• A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
• Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
• A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)
• Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
• Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
• Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
• Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
• Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
• The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
• Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
• A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
• Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
• Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
• Use of KC706 for the Treatment of Pemphigus Vulgaris
• Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
• Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
• Use of Infliximab for the Treatment of Pemphigus Vulgaris
• Effect of Anti CD20 in Pemphigus Desease
• Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
• European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
• Safety Study of PI-0824 to Treat Pemphigus Vulgaris
• Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus